Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years

Arne Kolstad*, Lone Bredo Pedersen, Christian W. Eskelund, Simon Husby, Kirsten Grønbæk, Mats Jerkeman, Anna Laurell, Riikka Räty, Erkki Elonen, Niels Smedegaard Andersen, Peter de Nully Brown, Eva Kimby, Hans Bentzen, Christer Sundström, Mats Ehinger, Marja Liisa Karjalainen-Lindsberg, Jan Delabie, Elisabeth Ralfkiær, Unn Merete Fagerli, Herman Nilsson-EhleGrete Fossum Lauritzsen, Outi Kuittinen, Carsten Niemann, Christian Hartman Geisler, the Nordic Lymphoma Group

*Corresponding author for this work
38 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years'. Together they form a unique fingerprint.

Medicine & Life Sciences